Medtronic PLC vs Synopsys, Inc. — how do they compare? Medtronic PLC trades at $90.5 (market cap $116.07B), while Synopsys, Inc. trades at $410.9 (market cap $78.68B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays a 3.18% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals.
| MDT | SNPS | |
|---|---|---|
Market Cap | $116.07B | $78.68B |
Sector | Health | Technology |
52-Week High | $105.35 | $625.80 |
52-Week Low | $73.75 | $372.33 |
Enterprise Value | $134.82B | $87.04B |
Dividend Yield | 3.18% | — |
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →